Analysis of the Putative Nucleoporin POM33 in the Filamentous Fungus Sordaria Macrospora
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
NIH Public Access Author Manuscript Science
NIH Public Access Author Manuscript Science. Author manuscript; available in PMC 2014 September 08. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Science. 2014 January 31; 343(6170): 506–511. doi:10.1126/science.1247363. Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders A full list of authors and affiliations appears at the end of the article. # These authors contributed equally to this work. Abstract Hereditary spastic paraplegias (HSPs) are neurodegenerative motor neuron diseases characterized by progressive age-dependent loss of corticospinal motor tract function. Although the genetic basis is partly understood, only a fraction of cases can receive a genetic diagnosis, and a global view of HSP is lacking. By using whole-exome sequencing in combination with network analysis, we identified 18 previously unknown putative HSP genes and validated nearly all of these genes functionally or genetically. The pathways highlighted by these mutations link HSP to cellular transport, nucleotide metabolism, and synapse and axon development. Network analysis revealed a host of further candidate genes, of which three were mutated in our cohort. Our analysis links HSP to other neurodegenerative disorders and can facilitate gene discovery and mechanistic understanding of disease. Hereditary spastic paraplegias (HSPs) are a group of genetically heterogeneous neurodegenerative disorders with prevalence between 3 and 10 per 100,000 individuals (1). Hallmark features are axonal degeneration and progressive lower limb spasticity resulting from a loss of corticospinal tract (CST) function. HSP is classified into two broad categories, uncomplicated and complicated, on the basis of the presence of additional clinical features such as intellectual disability, seizures, ataxia, peripheral neuropathy, skin abnormalities, and visual defects. -
Increased Expression of the Tail-Anchored Membrane Protein SLMAP in Adipose Tissue from Type 2 Tally Ho Diabetic Mice
Hindawi Publishing Corporation Experimental Diabetes Research Volume 2011, Article ID 421982, 10 pages doi:10.1155/2011/421982 Research Article Increased Expression of the Tail-Anchored Membrane Protein SLMAP in Adipose Tissue from Type 2 Tally Ho Diabetic Mice Xiaoliang Chen1 and Hong Ding2 1 Second People Hospital of Hangzhou, No. 1 Wenzhou Road, Hangzhou 310015, China 2 Department of Pharmacology, Weill Cornell Medical College in Qatar, P.O. Box 24144, Doha, Qatar Correspondence should be addressed to Hong Ding, [email protected] Received 6 April 2011; Accepted 5 May 2011 Academic Editor: N. Cameron Copyright © 2011 X. Chen and H. Ding. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The tail-anchored membrane protein, sarcolemmal membrane associated protein (SLMAP) is encoded to a single gene that maps to the chromosome 3p14 region and has also been reported in certain diabetic populations. Our previous studies with db/db mice shown that a deregulation of SLMAP expression plays an important role in type 2 diabetes. Male Tally Ho mice were bred to present with either normoglycemia (NG) or hyperglycemia (HG). Abdominal adipose tissue from male Tally Ho mice of the HG group was found to have a significantly lower expression of the membrane associated glucose transporter-4 (GLUT-4) and higher expression of SLMAP compared to tissue from NG mice. There were 3 isoforms expressed in the abdominal adipose tissue, but only 45 kDa isoform of SLMAP was associated with the GLUT-4 revealed by immunoprecipitation data. -
A Clearer Picture of the ER Translocon Complex Max Gemmer and Friedrich Förster*
© 2020. Published by The Company of Biologists Ltd | Journal of Cell Science (2020) 133, jcs231340. doi:10.1242/jcs.231340 REVIEW A clearer picture of the ER translocon complex Max Gemmer and Friedrich Förster* ABSTRACT et al., 1986). SP-equivalent N-terminal transmembrane helices that The endoplasmic reticulum (ER) translocon complex is the main gate are not cleaved off can also target proteins to the ER through the into the secretory pathway, facilitating the translocation of nascent same mechanism. In this SRP-dependent co-translational ER- peptides into the ER lumen or their integration into the lipid membrane. targeting mode, ribosomes associate with the ER membrane via ER Protein biogenesis in the ER involves additional processes, many of translocon complexes. These membrane protein complexes them occurring co-translationally while the nascent protein resides at translocate nascent soluble proteins into the ER, integrate nascent the translocon complex, including recruitment of ER-targeted membrane proteins into the ER membrane, mediate protein folding ribosome–nascent-chain complexes, glycosylation, signal peptide and membrane protein topogenesis, and modify them chemically. In cleavage, membrane protein topogenesis and folding. To perform addition to co-translational protein import and translocation, distinct such varied functions on a broad range of substrates, the ER ER translocon complexes enable post-translational translocation and translocon complex has different accessory components that membrane integration. This post-translational pathway is widespread associate with it either stably or transiently. Here, we review recent in yeast (Panzner et al., 1995), whereas higher eukaryotes primarily structural and functional insights into this dynamically constituted use it for relatively short peptides (Schlenstedt and Zimmermann, central hub in the ER and its components. -
X-Ray Structure of a Protein-Conducting Channel
articles X-ray structure of a protein-conducting channel Bert van den Berg1*, William M. Clemons Jr1*, Ian Collinson2, Yorgo Modis3, Enno Hartmann4, Stephen C. Harrison3 & Tom A. Rapoport1 1Howard Hughes Medical Institute and Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA 2Max Planck Institute of Biophysics, Marie-Curie-Strasse 13-15, D-60439 Frankfurt am Main, Germany 3Howard Hughes Medical Institute, Children’s Hospital and Harvard Medical School, 320 Longwood Avenue, Boston, Massachusetts 02115, USA 4University Luebeck, Institute for Biology, Ratzeburger Allee 160, Luebeck, D-23538, Germany * These authors contributed equally to this work ........................................................................................................................................................................................................................... A conserved heterotrimeric membrane protein complex, the Sec61 or SecY complex, forms a protein-conducting channel, allowing polypeptides to be transferred across or integrated into membranes. We report the crystal structure of the complex from Methanococcus jannaschii at a resolution of 3.2 A˚ . The structure suggests that one copy of the heterotrimer serves as a functional translocation channel. The a-subunit has two linked halves, transmembrane segments 1–5 and 6–10, clamped together by the g-subunit. A cytoplasmic funnel leading into the channel is plugged by a short helix. Plug displacement can open the channel into an ‘hourglass’ with a ring of hydrophobic residues at its constriction. This ring may form a seal around the translocating polypeptide, hindering the permeation of other molecules. The structure also suggests mechanisms for signal-sequence recognition and for the lateral exit of transmembrane segments of nascent membrane proteins into lipid, and indicates binding sites for partners that provide the driving force for translocation. -
TMEM33 (A-17): Sc-244421
SAN TA C RUZ BI OTEC HNOL OG Y, INC . TMEM33 (A-17): sc-244421 BACKGROUND PRODUCT TMEM33 (transmembrane protein 33), also known as protein DB83, is a 247 Each vial contains 200 µg IgG in 1.0 ml of PBS with < 0.1% sodium azide amino acid protein encoded by a gene mapping to human chromosome 4. and 0.1% gelatin. Representing approximately 6% of the human genome, chromosome 4 con - Blocking peptide available for competition studies, sc-244421 P, (100 µg tains nearly 900 genes. Notably, the Huntingtin gene, which is found to en- peptide in 0.5 ml PBS containing < 0.1% sodium azide and 0.2% BSA). code an expanded glutamine tract in cases of Huntington’s disease, is on chromosome 4. FGFR-3 is also encoded on chromosome 4 and has been asso - APPLICATIONS ciated with thanatophoric dwarfism, achondroplasia, Muenke syndrome and bladder cancer. Chromosome 4 is also tied to Ellis-van Creveld syndrome, TMEM33 (A-17) is recommended for detection of TMEM33 of mouse, rat methylmalonic acidemia and polycystic kidney disease. Chromosome 4 report - and human origin by Western Blotting (starting dilution 1:200, dilution range edly contains the largest gene deserts (regions of the genome with no protein 1:100-1:1000), immunofluorescence (starting dilution 1:50, dilution range encoding genes) and has one of the two lowest recombination frequencies 1:50-1:500) and solid phase ELISA (starting dilution 1:30, dilution range of the human chromosomes. 1:30-1:3000); non cross-reactive with other TMEM family members. TMEM33 (A-17) is also recommended for detection of TMEM33 in additional REFERENCES species, including equine, canine, bovine, porcine and avian. -
Macrophage Activation JUNB Is a Key Transcriptional Modulator Of
JUNB Is a Key Transcriptional Modulator of Macrophage Activation Mary F. Fontana, Alyssa Baccarella, Nidhi Pancholi, Miles A. Pufall, De'Broski R. Herbert and Charles C. Kim This information is current as of October 2, 2021. J Immunol 2015; 194:177-186; Prepublished online 3 December 2014; doi: 10.4049/jimmunol.1401595 http://www.jimmunol.org/content/194/1/177 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2014/12/03/jimmunol.140159 Material 5.DCSupplemental References This article cites 40 articles, 7 of which you can access for free at: http://www.jimmunol.org/content/194/1/177.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 2, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology JUNB Is a Key Transcriptional Modulator of Macrophage Activation Mary F. Fontana,* Alyssa Baccarella,* Nidhi Pancholi,* Miles A. -
Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing -
Hereditary Spastic Paraplegia: from Genes, Cells and Networks to Novel Pathways for Drug Discovery
brain sciences Review Hereditary Spastic Paraplegia: From Genes, Cells and Networks to Novel Pathways for Drug Discovery Alan Mackay-Sim Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia; a.mackay-sim@griffith.edu.au Abstract: Hereditary spastic paraplegia (HSP) is a diverse group of Mendelian genetic disorders affect- ing the upper motor neurons, specifically degeneration of their distal axons in the corticospinal tract. Currently, there are 80 genes or genomic loci (genomic regions for which the causative gene has not been identified) associated with HSP diagnosis. HSP is therefore genetically very heterogeneous. Finding treatments for the HSPs is a daunting task: a rare disease made rarer by so many causative genes and many potential mutations in those genes in individual patients. Personalized medicine through genetic correction may be possible, but impractical as a generalized treatment strategy. The ideal treatments would be small molecules that are effective for people with different causative mutations. This requires identification of disease-associated cell dysfunctions shared across geno- types despite the large number of HSP genes that suggest a wide diversity of molecular and cellular mechanisms. This review highlights the shared dysfunctional phenotypes in patient-derived cells from patients with different causative mutations and uses bioinformatic analyses of the HSP genes to identify novel cell functions as potential targets for future drug treatments for multiple genotypes. Keywords: neurodegeneration; motor neuron disease; spastic paraplegia; endoplasmic reticulum; Citation: Mackay-Sim, A. Hereditary protein-protein interaction network Spastic Paraplegia: From Genes, Cells and Networks to Novel Pathways for Drug Discovery. Brain Sci. 2021, 11, 403. -
Expression of a Novel Reticulon-Like Gene in Human Testis
Reproduction (2002) 123, 227–234 Research Expression of a novel reticulon-like gene in human testis Z. M. Zhou1,2, J. H. Sha2, J. M. Li2 , M. Lin2, H. Zhu2, Y. D. Zhou2, L. R. Wang2, H. Zhu2, Y. Q. Wang1 and K. Y. Zhou1 1Institute of Genetic Resources, Nanjing Normal University, Nanjing, Jiangsu Province 210029, People’s Republic of China; and 2Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu Province, 210029, People’s Republic of China Identification of genes that are specifically expressed in the had 968 amino acids. This protein is homologous to the adult testis or the fetal testis is important for the study of six known members of the Rtn family (KIAA0886, Rtn xL, genes related to the development of the testis. In this study, reticulon 4a, Nogo-A, Nogo-A short form, and brain my043) a human testis cDNA microarray was established. PCR but was different at the 5’ end. All homologues originate products of 9216 clones from a human testis cDNA library from one gene, and result from both different promotor were dotted on a nylon membrane; mRNA from adult and regions and different splicing. Rtn-T lacks the first exon and fetal testes were purified and probes were prepared by a contains a second exon that is lacking in the other reverse transcription reaction with testis mRNA as template. homologues. Rtn-T is shorter than KIAA0886, Rtn xL, The microarray was hybridized with probes of adult and reticulon 4a and Nogo-A, but longer than the Nogo-A short fetal testes, and 96.8 and 95.4% of clones were positive, form and brain my043. -
Active and Passive Displacement of Transmembrane Domains Both Occur During Opsin Biogenesis at the Sec61 Translocon
2826 Research Article Active and passive displacement of transmembrane domains both occur during opsin biogenesis at the Sec61 translocon Nurzian Ismail, Samuel G. Crawshaw and Stephen High* Faculty of Life Sciences, University of Manchester, The Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK *Author for correspondence (e-mail: [email protected]) Accepted 13 April 2006 Journal of Cell Science 119, 2826-2836 Published by The Company of Biologists 2006 doi:10.1242/jcs.03018 Summary We used a site-specific crosslinking approach to study the that its lateral exit from the translocon is clearly dependent membrane integration of the polytopic protein opsin at the upon the synthesis of subsequent transmembrane domains. endoplasmic reticulum. We show that transmembrane By contrast, the lateral exit of the third transmembrane domain 1 occupies two distinct Sec61-based environments domain occurred independently of any such requirement. during its integration. However, transmembrane domains Thus, even within a single polypeptide chain, distinct 2 and 3 exit the Sec61 translocon more rapidly in a process transmembrane domains display different requirements that suggests a displacement model for their integration for their integration through the endoplasmic reticulum where the biosynthesis of one transmembrane domain translocon, and the displacement of one transmembrane would facilitate the exit of another. In order to investigate domain by another is not a global requirement for this hypothesis further, we studied the integration -
Leveraging Tissue Specific Gene Expression Regulation to Identify Genes Associated with Complex Diseases
bioRxiv preprint doi: https://doi.org/10.1101/529297; this version posted January 23, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Leveraging tissue specific gene expression regulation to identify genes associated with complex diseases Wei Liu1,#, Mo Li2,#, Wenfeng Zhang2, Geyu Zhou1, Xing Wu4, Jiawei Wang1, Hongyu Zhao1,2,3* 1 Program of Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA 06510 2 Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA 06510 3 Department of Genetics, Yale School of Medicine, New Haven, CT, USA 06510 4 Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA 06510 # These authors contributed equally to this work * To Whom correspondence should be addressed: Dr. Hongyu Zhao Department of Biostatistics Yale School of Public Health 60 College Street, New Haven, CT, 06520, USA [email protected] Key words: GWAS; gene expression imputation; Alzheimer’s disease; gene-level association test 1 bioRxiv preprint doi: https://doi.org/10.1101/529297; this version posted January 23, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract To increase statistical power to identify genes associated with complex traits, a number of methods like PrediXcan and FUSION have been developed using gene expression as a mediating trait linking genetic variations and diseases. -
Identification and Characterization of TMEM33 As a Reticulon-Binding Protein
Kobe J. Med. Sci., Vol. 60, No. 3, pp. E57-E65, 2014 Identification and Characterization of TMEM33 as a Reticulon-binding Protein TAKESHI URADE1,2, YASUNORI YAMAMOTO1, XIA ZHANG1, YONSON KU2, and TOSHIAKI SAKISAKA*1 1Division of Membrane Dynamics, Department of Physiology and Cell Biology, 2Division of Hepato-biliary-pancreatic surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe 650-0017 Japan Received 16 July, 2014/ Accepted 31 July, 2014 Key words: TMEM33, Reticulon, ER tubules ABSTRACT Endoplasmic reticulum (ER) is an organelle that has an elaborate and continuous membrane system composed of sheet-like cisternae and a network of interconnected tubules. The ER tubules are shaped by reticulons, a conserved ER membrane protein family. However, how the membrane-shaping activity is regulated remains to be elucidated. To understand the mode of action of reticulons, we isolated TMEM33, a conserved protein harboring three transmembrane domains, as a reticulon 4C-binding protein by affinity chromatography. In addition to reticulon 4C, TMEM33 binds to reticulon 1A, -2B, -3C and a reticulon homology domain-containing protein Arl6IP1. Exogenously expressed TMEM33 localizes at both the ER membrane and the nuclear envelope. Exogenously expressed TMEM33 co-localizes with exogenously expressed reticulon 4C well at the ER sheets and partially at the ER tubules. Exogenously expressed TMEM33 suppresses the exogenously expressed reticulon 4C-induced tubulation of ER. These results suggest that TMEM33 has a potency to suppress the membrane-shaping activity of reticulons, thereby regulating the tubular structure of ER. INTRODUCTION The ER (endoplasmic reticulum) is a continuous membrane system extended from nuclear envelope and composed of interconnected sheets and tubules [11,20,21,25,28].